Trademarkia Logo

Australia

AU$
Trademark Search
REBLOZYL

View On IPO.GOV.AU

REBLOZYL
Protected: Registered/protected

Last updated on 14 Nov 2024

Owner Info

Celgene Corporation

Route 206 & Province Line Road

Princeton NJ 08543, UNITED STATES OF AMERICA

Serial Number

2090137 filed on 10 Mar 2020

Correspondent

KIRKPATRICK, SA/NV

Avenue Wolfers 32,

B-1310 La Hulpe,

BELGIUM

REBLOZYL

Classification Information

Class [005]
Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease and cancer.

Mark Details

Serial Number

2090137

Registered On

10 Mar 2020

Renewal On

10 Mar 2030

Mark Type

FIGURATIVE

Priority Claim (Convention Details)

Date

5 Mar 2020

Mark Type

US

Legal History

Show more

Status DateAction Taken
14th Nov 2024Amendment to Amend Owner Requested
7th Sept 2023Amendment to International Registration Contact Requested
14th Jul 2021IP right goods and service classes updated
14th Jul 2021IP Right Goods and Services Items updated
6th May 2021Amendment to International Registration Contact Requested
12th Nov 2020International Registration in Australia Protected correspondence sent
11th Nov 2020IP Right Registration Published
11th Nov 2020Status change to Registered/Protected
5th Sept 2020Application Accepted correspondence sent
4th Sept 2020IP Right has been Examined